Thromb Haemost 1993; 69(01): 064-069
DOI: 10.1055/s-0038-1651550
Original Article
Platelets
Schattauer GmbH Stuttgart

Application of GPIIIa Gene Taq I Polymorphism to Determination of Carrier Status in Glanzmann’s Thrombasthenia Families of Chinese Origin

Changgeng Ruan
The Jiangsu Institute of Haematology, Thrombosis and Haemostasis Research Unit, Suzhou Medical College, The People’s Republic of China
,
Jianming Gu
The Jiangsu Institute of Haematology, Thrombosis and Haemostasis Research Unit, Suzhou Medical College, The People’s Republic of China
,
Xiaodong Wang
The Jiangsu Institute of Haematology, Thrombosis and Haemostasis Research Unit, Suzhou Medical College, The People’s Republic of China
,
Xiaohong Chu
The Jiangsu Institute of Haematology, Thrombosis and Haemostasis Research Unit, Suzhou Medical College, The People’s Republic of China
,
Junliang Pan
The Jiangsu Institute of Haematology, Thrombosis and Haemostasis Research Unit, Suzhou Medical College, The People’s Republic of China
› Author Affiliations
Further Information

Publication History

Received 02 March 1992

Accepted after revision 27 August 1992

Publication Date:
04 July 2018 (online)

Summary

Glanzmann’s thrombasthenia is a bleeding disorder caused by qualitative and/or quantitative defects of platelet membrane glycoprotein (GP) IIb/IIIa complex. The disease is inherited in an autosomal recessive manner. In this paper, cDNA probes were used to study restriction fragment length polymorphisms (RFLPs) in GPIIIa gene. A Taq I polymorphism was identified and this RFLP was composed of variant bands of 6.5 Kb/4.0 and 2.5 Kb with a frequency of 0.46/0.54 in Chinese population. The Taq I polymorphism was further localized by polymerase chain reaction (PCR) method to exon VIII of the GPIIIa gene. In two Glanzmann’s thrombasthenia families, the Taq I RFLP studied by both Southern blotting and PCR methods identified the defective GPIIIa gene inherited by patients, and determined the genotype of asymptomatic subjects. Analysis of this Taq I polymorphism by PCR method should be potentially useful in future for the carrier detection and prenatal diagnosis in Glanzmann’s thrombasthenia families.

 
  • References

  • 1 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1400
  • 2 Ruggeri ZM, Bader R, DeMarco L. Glanzmann’s thrombasthenia: Deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci USA 1982; 79: 6038-6041
  • 3 Ginsberg MH, Forsyth J, Lightsey A, Chediak J, Plow EF. Reduced surface expression and binding fibronectin by thrombin-stimulated thrombasthenic platelets. J Clin Invest 1983; 71: 619-624
  • 4 Pytela R, Pierscher MD, Ginsberg MH, Plow EF, Ruoslati E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986; 23: 1159-1162
  • 5 Plow EF, McEver RP, Coller BS, Woods VL, Margurie GA, Ginsberg MH. Related binding mechanism for fibrinogen, fibronectin, von Willebrand factor and thrombospondin on thrombin-stimulated human platelets. Blood 1985; 66: 724-727
  • 6 Karczewski J, Knudsen KA, Smith L, Murphy A, Rothman VL, Tuszynski GP. The interaction of thrombospondin with platelet glycoprotein IIb-IIIa. J Biol Chem 1989; 264: 21322-21326
  • 7 Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974; 28: 253-260
  • 8 George JN, Caen JP, Nurden AT. Glanzmann’s thrombasthenia: The spectrum of clinical disease. Blood 1990; 75: 12383-12395
  • 9 Fitzgerald LD, Steiner B, Rall SC, Lo SS, Phillips DR. Protein sequence of endothelial glycoprotein IIIa and similarity to “integrin”. J Biol Chem 1987; 262: 3936-3939
  • 10 Poncz M, Eisman R, Heidenreich R, Silver SM, Vilaire G, Surrey S, Schwartz E, Bennett JS. Structure of the platelet membrane glycoprotein IIb: Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 1987; 262: 8476-8482
  • 11 Zimrin AB, Eisman R, Vilaire G, Schwartz E, Bennett JS, Poncz M. Structure of platelet glycoprotein IIIa: a common subunit for two different membrane receptors. J Clin Invest 1988; 81: 1470-1475
  • 12 Bray PF, Rosa J-P, Johnston GT, Shiu DT, Cook RG, Lau C, McEver RP, Shuman MA. Platelet glycoprotein IIb: chromosome localization and tissue expression. J Clin Invest 1987; 80: 1812-1817
  • 13 Rosa J-P, Bray PF, Gayet O, Johnston GI, Cook RG, Jackson KW, Shuman MA, McEver RP. Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood 1988; 72: 593-600
  • 14 Bray PF, Barsh G, Rosa J-P, Lu XY, Magenis E, Shuman MA. Physical linkage of the genes for platelet membrane glycoprotein IIb and IIIa. Proc Natl Acad Sci USA 1988; 85: 8683-8687
  • 15 Heidenreich R, Eisman R, Surrey S, Delgrosso K, Bennett JS, Schwartz E, Poncz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry 1990; 29: 1232-1244
  • 16 Zimrin AB, Gidwitz S, Lord S, Schwartz E, Bennett JS, White II GC, Poncz M. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990; 265: 8590-8595
  • 17 Loftus JC, O’Toole TE, Plow EF, Glass A, Frelinger III AL, Ginsberg MH. A β3 integrin mutation abolishes legend binding and alters divalent cation-dependent conformation. Science 1990; 249: 915-918
  • 18 Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann’s thrombasthenia in the Iraqi-Jewish and Arab population in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-3164
  • 19 Burk CD, Newman PJ, Lyman S, Gill J, Coller BS, Poncz M. A deletion in the gene for glycoprotein IIb associated with Glanzmann’s thrombasthenia. J Clin Invest 1991; 87: 270-276
  • 20 Bray PF, Shuman MA. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann’s thrombasthenia. Blood 1990; 75: 881-888
  • 21 Bray PF, Shuman MA. Molecular analysis of the genes for platelet glycoprotein IIb (GPIIb) and IIIa (GPIIIa) in a normal population and a family with Glanzmann thrombasthenia: Identification and a family with Glanzmann’s thrombasthenia: Identification of two polymorphisms and a rearranged GPIIIa gene. Blood 1988; 72: 317a
  • 22 Burk CD, Ingram C Weiner M, Rappaport EF, Schwartz E, Poncz M. A Taq I polymorphism for the human platelet glycoprotein IIIa gene (GP3A). Nucleic Acids Res 1988; 16: 7216
  • 23 Peretz H, Seligsohn U, Zwang E, Coller BS, Newman PJ. Detection of the Glanzmann’s thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples. Thromb Haemostas 1991; 66: 500-504
  • 24 Baenziger NL, Majerus PW. Isolation of human platelets and platelets surface membranes. Meth Enzymol 1974; 31: 149-155
  • 25 Ruan CG, Du XP, Wan HY, Li PX, Gu JM. Studies on monoclonal antibody - SZ 21 to platelet membrane glycoprotein IIIa. Natl Med J China 1987; 67: 76-80
  • 26 Ruan CG, Wan HY, Du XP, Hu XY, Li PX. Studies on a monoclonal antibody to platelet membrane glycoprotein IIb-SZ 22. Chinese J Hematol 1988; 9: 156-161
  • 27 Maniatis T, Fritsch EF, Sambrook J. (eds). Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press; New York: 1982: 280
  • 28 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517
  • 29 Feinberg AP, Vogelstein B. Technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-12
  • 30 Wu QY, Bahnak BR, Coulombel L, Kerbiriou-Nabias D, Drouet L, Pietu G, Meulien P, Pavirani A, Caen JP, Meyer D. Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease using a human cDNA probe. Blood 1988; 71: 1341-1346
  • 31 Saiki RK, Gelfand DH, Stoffel S, Scharf SH, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
  • 32 Coller BS, Seligsohn U, Zivilin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann’s thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection. Br J Haematol 1986; 62: 723-735
  • 33 Grodzicker T, Williams T, Sharp P, Sambrook J. Physical mapping of temperature sensitive mutations of adenoviruses. Cold Spring Harbor Symp Quandt Biol 1974; 39: 439-446
  • 34 Botstein D, White RL, Skolnick M, Davis RW. Construction of genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 1980; 32: 314-331